The time has come to build efficient working relationships between pharmacovigilance centres and medication error reporting and learning programmes in order to maximize the public health benefits of spontaneous reporting of medication errors. With such cooperation, information on medication safety will be better organized and managed in such a way as to be more efficiently utilized as a resource for learning how to develop medication use systems that are continually safer for patients.
IMSN, which is composed of some of the world’s leading medication safety expert physicians and pharmacists, stands ready to communicate directly with the world’s pharmacovigilance leaders to further the cause of medication safety.
Position Paper on Pharmacovigilance and Medication Errors
Adverse drug reactions and medication errors are two sides of the same coin: medication safety. Cooperation between pharmacovigilance and medication error or patient safety incident reporting systems should be clearly described, particularly regarding the conditions and the nature of exchanges between these entities. (October 2009) Download PDF
Comment on EU pharmacovigilance legislative proposals
The time has come to build efficient working relationships between pharmacovigilance centres and medication errors reporting and learning systems. IMSNPC Letter to the European Commission (January 31, 2008) Dowload PDF